Can stopping sertraline cause a stop‑and‑start tinnitus that appears one day after discontinuation, resolves, and then returns a few days later?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Yes, intermittent tinnitus during sertraline discontinuation is a recognized withdrawal symptom

Stopping sertraline abruptly can cause discontinuation syndrome with fluctuating symptoms including tinnitus that may appear, resolve, and recur over days to weeks. This stop-and-start pattern you're experiencing is consistent with SSRI withdrawal.

Understanding Your Symptoms

Your timeline—tinnitus on day 1, resolution on day 2, then recurrence on day 3—fits the characteristic pattern of sertraline discontinuation syndrome. The FDA drug label explicitly warns that stopping sertraline too quickly can cause "electric shock-like sensations, shaking, confusion" along with other neurological symptoms 1. While tinnitus isn't listed as prominently as dizziness or sensory disturbances, it falls within the spectrum of discontinuation effects.

Sertraline is specifically identified as one of three SSRIs most associated with discontinuation syndrome (along with paroxetine and fluvoxamine) 2. The symptoms can be erratic and wax-and-wane rather than following a predictable linear course.

Why This Happens

The fluctuating nature occurs because:

  • Sertraline has a relatively short half-life (approximately 26 hours), so brain serotonin levels drop relatively quickly after stopping
  • Your nervous system is attempting to readjust to the absence of the medication, causing temporary instability in auditory processing
  • Withdrawal symptoms are "generally self-limiting" but can persist for up to 3 weeks 3
  • The symptoms may improve, worsen, or fluctuate as your serotonergic system recalibrates 1

Research confirms that tinnitus can occur both as a side effect during SSRI treatment AND as a discontinuation symptom when stopping 4, 5, 6. One case report specifically documented tinnitus developing during venlafaxine (another serotonergic antidepressant) discontinuation that persisted even after restarting the medication 6.

What You Should Do

Contact your prescriber immediately. Guidelines emphasize that "a gradual reduction in the dose rather than abrupt cessation is recommended whenever possible" 1. Your options include:

  1. Restart sertraline at your previous dose and taper more slowly (the FDA label suggests this approach if intolerable symptoms occur) 1
  2. Monitor closely if symptoms are tolerable—most discontinuation symptoms resolve within 1-3 weeks 3
  3. Rule out other causes if tinnitus persists beyond 3 weeks after complete discontinuation

Critical Warnings

Do not ignore persistent or worsening symptoms. While discontinuation syndrome is typically self-limiting, you should seek immediate medical attention if you develop:

  • Severe dizziness or vertigo
  • Confusion or significant mood changes
  • Any symptoms suggesting serotonin syndrome (though this is more common when starting, not stopping)
  • Tinnitus that persists beyond 3-4 weeks after complete discontinuation (may indicate an unrelated cause requiring audiological evaluation) 7, 8

The key message: Your fluctuating tinnitus is likely a withdrawal symptom from stopping sertraline too quickly. The proper approach is gradual tapering under medical supervision, not abrupt cessation 9.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.